Project Grant K23MH137382
- This $136,113 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research on the neural mechanisms underlying the co-occurrence of depression and anxiety in adolescents. The research aims to use advanced network analysis techniques to identify disturbances in brain networks that are shared by emerging depression and anxiety, providing critical insights into the prevention and treatment of these mental...
- This federal Project Grant award of $1,440,659, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), is funding the development and testing of a novel group intervention called "Perinatal Dialectical Behavior Therapy Skills (DBT-P)" to address emotion dysregulation during pregnancy. The goal is to improve maternal emotion regulation skills, with the aim of positively impacting infant neurobehavioral and...
- This Project Grant award of $237,000 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research by Northeastern University to investigate the role of the hormone allopregnanolone in producing long-term alterations in brain activity and behavior related to pregnancy and motherhood. The research aims to establish a causal, mechanistic link between the hormonal changes of pregnancy and the subsequent neural and...
- The National Institute of Mental Health (NIMH), through the Mental Health Research Grants program (CFDA 93.242), awarded a $759,581 project grant to The McLean Hospital Corporation located in Belmont, MA. The grant, titled "Harnessing Smartphones for Real-Time Detection of Affective Disturbance and Future Depression Risk in Adolescents," will fund research to develop data-driven approaches to predict and interrupt states of high negative affective states (e.g., sadness, anger, anxiety)...
- The U.S. National Institute of Mental Health (NIMH) awarded a $154,796 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Trustees of Princeton University to conduct research on understanding fear relapse and its relationship to anxiety. The key objectives of this 5-year project are to: 1) leverage latent cause inference modeling to quantify individual differences in the computational processes underlying spontaneous recovery of fear during extinction, 2)...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Federal Grant Program titled "Mental Health Research Grants" (CFDA 93.242), provides $418,750.00 to Yale University to mechanistically uncover the neuroanatomical substrates of anxiety-related brain circuits. The research aims to improve the understanding and treatment of anxiety disorders, which affect 1 in 14 people worldwide. The 5-year project, beginning on February 1, 2025, will utilize...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $256,627.00 to the University of Denver to develop and pilot test a digital intervention for parents of pre- and early adolescents. The goal is to support parents in responding effectively to suicide risk alerts generated by digital monitoring apps, thereby decreasing suicide-related behaviors in their children. The project involves three phases:...
- The National Institute of Mental Health (NIMH) awarded a $780,698 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Wisconsin - Madison. The 4-year grant aims to optimize the integration of human and digital support in a meditation app to address the public health burden of depression and anxiety. The project will examine the effects of adding introductory coaching, on-demand email-based coaching, and digital prompts to the Healthy Minds Program...
- This Project Grant award of $782,279 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to better understand and treat avoidance behaviors associated with anxiety disorders. The research will use an interdisciplinary approach to combine neural and behavioral data to validate a novel computational model of avoidance, test differences in avoidance behavior in individuals with clinically impairing anxiety, and examine if the...
- The National Institute of Mental Health (NIMH) awarded a $191,700 project grant under the Mental Health Research Grants program (CFDA 93.242) to Northwestern University to conduct computational modeling and neuroscientific research on ambiguity aversion as a potential mechanism underlying internalizing disorders such as anxiety and depression. The 5-year project aims to (1) examine behavioral and neurophysiological markers of ambiguity aversion in a transdiagnostic sample, and (2) test whether...
The Project Grant award titled "REACHING CALM: A DIGITAL INTERVENTION TO PREVENT PERINATAL ANXIETY DISORDERS" was provided by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242). This $159,743 award, effective September 15, 2025, will support research conducted by the University of Massachusetts Medical School (UMASS Medical) to develop a digital intervention aimed at preventing perinatal anxiety disorders. The project seeks to transform healthcare systems and address the high prevalence of anxiety disorders among perinatal individuals, particularly those with low socioeconomic status. The research will explore the use of anxiety sensitivity interventions, a cognitive-behavioral-based approach to prevention, to improve outcomes for this population.